Skip to main navigation Skip to search Skip to main content

Evaluating the efficacy and safety of neoadjuvant pembrolizumab in patients with stage I-III MMR-deficient colon cancer: a national, multicentre, prospective, single-arm, phase II study protocol

  • Tobias Freyberg Justesen*
  • , Ismail Gögenur
  • , Line Schmidt Tarpgaard
  • , Per Pfeiffer
  • , Camilla Qvortrup
    • *Corresponding author for this work

Research output: Contribution to journal › Protocol › peer-review

Fingerprint

Explore the research areas of 'Evaluating the efficacy and safety of neoadjuvant pembrolizumab in patients with stage I-III MMR-deficient colon cancer: a national, multicentre, prospective, single-arm, phase II study protocol'.
Sort by

Keyphrases

Medicine and Dentistry